Verici Dx plc (LON:VRCI – Get Free Report)’s stock price shot up 31.8% during mid-day trading on Thursday . The company traded as high as GBX 3.63 ($0.05) and last traded at GBX 3.63 ($0.05). 959,982 shares changed hands during trading, an increase of 65% from the average session volume of 581,209 shares. The stock had previously closed at GBX 2.75 ($0.04).
Verici Dx Stock Up 30.9 %
The firm has a market cap of £10.93 million, a price-to-earnings ratio of -2.09 and a beta of 1.59. The company has a debt-to-equity ratio of 4.64, a current ratio of 4.54 and a quick ratio of 8.49. The stock has a 50-day moving average of GBX 3.76 and a 200-day moving average of GBX 4.34.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- What is a penny stock? A comprehensive guide
- Broaden Your ETF Exposure With These 3 Overlooked Funds
- There Are Different Types of Stock To Invest In
- 2 Stocks Insiders Are Buying and 1 They’re Selling
- Earnings Per Share Calculator: How to Calculate EPS
- 2 Must-Have Stocks as Consumers Prioritize Needs Over Wants
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
